Features | Partner Sites | Information | LinkXpress
Sign In
Demo Company

New Line of DNA Amplification Reagents Promises Consistent Results Across All PCR Instruments

By BiotechDaily International staff writers
Posted on 02 Sep 2013
Image: iTaq Universal SYBR Green Supermix (Photo courtesy of Bio-Rad).
Image: iTaq Universal SYBR Green Supermix (Photo courtesy of Bio-Rad).
New reagent mixes specially formulated for PCR applications are now available for biotech and genomics researchers.

Bio-Rad Laboratories, Inc. (Hercules, CA, USA) recently launched two iTaq universal one-step kits aimed to deliver superior data precision and highly efficient reverse transcription quantitative PCR (RT-qPCR) performance under most reaction conditions on any qPCR instrument.

The new iTaq universal one-step kit line includes the iTaq universal SYBR Green one-step kit and the iTaq universal probes one-step kit. Both kits come as a double concentrated, ready-to-use reaction mixes with iScript reverse transcriptase optimized for RT-qPCR.

The iTaq universal SYBR Green one-step kit includes SYBR Green I dye and Bio-Rad’s patented RT inhibitor reducer. The iTaq universal probes one-step kit allows researchers to combine multiple targets in one well (multiplexing), improving data precision and reducing costs.

The new kits enable investigators to obtain reliable and reproducible gene expression-analysis results while amplifying genomic DNA and difficult amplicons with superior efficiency. Results are consistent across real-time instrument platforms under fast or standard conditions.

The Bio-Rad Kits are intended for gene expression analysis, genotyping, mutation detection, and pathogen detection.

Related Links:
Bio-Rad Laboratories, Inc.



view channel
Image: Schematic representation of HIV DART binding to two distinct antigens simultaneously, redirecting the killer T-cells to destroy HIV-1 infected cells (Photo courtesy of Duke University).

Bi-Specific Antibodies Shown to Clear Latent HIV Infections

Bi-specific antibodies or DARTS (dual-affinity re-targeting proteins) have been used to eliminate latent HIV-infection from patient samples by redirecting polyclonal T-cells to specifically engage with... Read more

Drug Discovery

view channel
Image: Use of catchphrase terms like “breakthrough” and “promising” in public news media presenting new drugs tends to result in incorrect assumptions and conclusions about the meaning and significance of criteria for FDA breakthrough-designated and accelerated-approval drugs (Photo courtesy of Dartmouth Institute).

Words That Inappropriately Enhance Perception of New Drug’s Effectiveness

Researchers have found that using the words “breakthrough” and “promising” in presenting a new drug to the general public often has a dramatic effect on judgment about its effectiveness.... Read more


view channel

Sale of Mexican Pharmaceutical Company Expected to Boost Latin American Prescription Drug Market

The sale of a major Mexican pharmaceutical company to an international generic drug corporation is expected to accelerate the growth of the Latin American market for prescription drugs. Teva Pharmaceutical Industries Ltd. (Petah Tikva, Israel) announced that it has entered into definitive agreements to buy Representaciones... Read more


17 Oct 2015 - 21 Oct 2015
25 Oct 2015 - 29 Oct 2015
16 Nov 2015 - 19 Nov 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.